Sort
326,823 grants matching “clinical trial”
Combining Testosterone Therapy and Exercise to Improve Function Post Hip Fracture
$3,021,234Ellen F Binder · Washington University · R01 · FY2022 · AG
Division of Microbiology and Infectious Diseases (DMID) Clinical Materials Services
$3,021,046John Kudrick · Fisher Bioservices, Inc. · N01 · FY2021 · AI
Development of Recombinant Toxins to Treat Hematologic Malignancies
$3,020,282Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
LOW BACK PAIN--A MULTICENTER RANDOMIZED TRIAL
$3,020,050Dartmouth College · U01 · FY2001 · AR
Upstate Carolina Consortium - Community Oncology Research Program
$3,019,697James D Bearden · Spartanburg Regional Medical Center · UG1 · FY2022 · CA
The Sylvester Cancer Center Support Grant
$3,019,497Stephen David Nimer · University Of Miami School Of Medicine · P30 · FY2025 · CA
Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect
$3,019,176Carlos Zarate · National Institute Of Mental Health · ZIA · FY2020 · MH
Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders
$3,019,176Carlos Zarate · National Institute Of Mental Health · ZIA · FY2020 · MH
Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II
$3,019,032Michael Alosco · Boston University Medical Campus · R01 · FY2025 · NS
MU-JHU HPTU TRIAL SITE - UGANDA
$3,018,422Johns Hopkins University · U01 · FY2005 · AI
Design of single-shot sequential immunization regimens for HIV using atomic layer deposition technology.
$3,017,032Darrell J Irvine · Scripps Research Institute, The · R01 · FY2025 · AI
Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder
$3,016,228Christian Arthur Heidbreder · Indivior, Inc. · UG3 · FY2019 · DA
Carotid Revascularization Endarterectomy vs. Stenting Trial: Long Term Follow-up
$3,015,984Thomas G Brott · Rbhs-New Jersey Medical School · U01 · FY2013 · NS
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$3,015,851Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2016 · AI
StATins Use in intRacerebral hemorrhage patieNts (SATURN)
$3,014,650Magdy H Selim · Beth Israel Deaconess Medical Center · U01 · FY2019 · NS
South Texas Alzheimer's Disease Center
$3,014,460Sudha Seshadri · University Of Texas Hlth Science Center · P30 · FY2021 · AG
Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU
$3,014,456Daniel R Kuritzkes · Massachusetts General Hospital · U01 · FY2007 · AI
Nutrition Precision Health for All of Us (Chicago Center)
$3,014,106Linda V Van Horn · Northwestern University At Chicago · UG1 · FY2023 · HD
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$3,013,746Leonard Neckers · Clinical Sciences · Z01 · FY2007 · CA
Genetic and Environmental Determinants of Triglycerides
$3,013,681University Of Alabama At Birmingham · U01 · FY2004 · HL
Building on the success of the adoptive immunotherapy of cancer
$3,013,441Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
THE UNIVERSITY OF ROCHESTER'S CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE
$3,012,900Thomas A Pearson · University Of Rochester · UL1 · FY2010 · RR
CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures
$3,012,837Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Bone Marrow Transplantation in Human Disease
$3,012,562Richard J Jones · Johns Hopkins University · P01 · FY2009 · CA
Data Resource for Analyzing Blood & Marrow Transplants
$3,011,884Mary M Horowitz · Medical College Of Wisconsin · U24 · FY2006 · CA